Nuhey News

We talk about the MARKET

Global Age Related Macular Degeneration Drug Market Overview and Analysis of Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma and more

Age-Related Macular Degeneration (AMD) is a degenerative eye condition that can lead to vision loss in people over the age of 50. It is the leading cause of severe vision loss in people over the age of 65 in the United States. AMD affects the macula, the part of the retina that is responsible for central vision. People with AMD have difficulty with tasks such as reading, driving, or recognizing faces.

Currently, there is no cure for AMD. However, there are treatments available to slow the progression of the disease. The most common treatments are anti-VEGF injections, photodynamic therapy, and laser therapy. These treatments work by limiting the growth of abnormal blood vessels and reducing the swelling in the macula.

In addition to these medical treatments, there are lifestyle changes that can help reduce the risk of AMD. These include quitting smoking, exercising regularly, eating a healthy diet, and wearing sunglasses to protect the eyes from UV rays.

Globally, AMD is estimated to affect more than 196 million people. The incidence of AMD is expected to double by the year 2040. As the global population continues to age, the prevalence of AMD is likely to increase.

The global Age Related Macular Degeneration Drug market was valued at US$ 7725.7 million in 2022 and is anticipated to reach US$ 11590 million by 2029, witnessing a CAGR of 5.9% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

A detailed market research report on Global Age Related Macular Degeneration Drug Market available at: https://www.themarketreports.com/report/global-age-related-macular-degeneration-drug-market-research-report

This report aims to provide a comprehensive presentation of the global market for Age Related Macular Degeneration Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age Related Macular Degeneration Drug.

The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.

Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1419766

Release by:

Shirish Gupta

Marketing Manager

The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479

Email:sales@themarketreports.com